PCM
TRAW icon

Perkins Capital Management’s Traws Pharma TRAW Stock Holding History

Perkins Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,000
Closed -$105K – 108
2020
Q3 		$105K Buy
+1,000
New +$247K 0.1% 83
2020
Q1 		$48K Buy
+427
New +$67K 0.06% 92

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWA
Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Perkins Capital Management's TRAW Position: Q4 2020 in Review

Perkins Capital Management sold out of Traws Pharma (TRAW) in Q4 2020, closing a stake of 1,000 shares — an estimated $105K sold.

Perkins Capital Management first reported a position in TRAW in Q1 2020 and held it in 2 quarters. The position peaked at $105K in Q3 2020. 33 funds tracked by Wall St. Rank hold TRAW as of Q4 2020.

  • Perkins Capital Management reported no remaining Traws Pharma position as of Q4 2020 after selling out during the quarter.
  • Perkins Capital Management sold 1,000 Traws Pharma shares in Q4 2020, an estimated $105K.
  • Perkins Capital Management first reported a position in Traws Pharma in Q1 2020 and held it in 2 quarters.
  • Perkins Capital Management's Traws Pharma position peaked at $105K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2020.

Based on Perkins Capital Management's 13F filing for Q4 2020, filed 9 Feb 2021.